Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sexual Partners | 39 | 2022 | 314 | 12.060 |
Why?
|
Homosexuality, Male | 41 | 2023 | 458 | 11.920 |
Why?
|
HIV Infections | 46 | 2023 | 2303 | 8.550 |
Why?
|
Sexual Behavior | 27 | 2022 | 609 | 7.080 |
Why?
|
Unsafe Sex | 9 | 2018 | 161 | 3.810 |
Why?
|
HIV Seronegativity | 7 | 2016 | 39 | 3.110 |
Why?
|
Family Characteristics | 14 | 2018 | 108 | 3.000 |
Why?
|
Interpersonal Relations | 9 | 2022 | 205 | 2.540 |
Why?
|
Patient Acceptance of Health Care | 8 | 2021 | 404 | 2.400 |
Why?
|
Sexually Transmitted Diseases | 4 | 2023 | 164 | 2.250 |
Why?
|
Negotiating | 5 | 2017 | 25 | 2.080 |
Why?
|
Health Knowledge, Attitudes, Practice | 12 | 2021 | 864 | 2.080 |
Why?
|
Internet | 10 | 2020 | 211 | 2.080 |
Why?
|
Telemedicine | 6 | 2022 | 182 | 1.980 |
Why?
|
HIV Seropositivity | 7 | 2018 | 190 | 1.910 |
Why?
|
Cross-Sectional Studies | 26 | 2023 | 2721 | 1.900 |
Why?
|
Mass Screening | 6 | 2020 | 462 | 1.900 |
Why?
|
Adult | 42 | 2023 | 11712 | 1.770 |
Why?
|
Male | 54 | 2023 | 20025 | 1.760 |
Why?
|
Trust | 9 | 2022 | 133 | 1.590 |
Why?
|
Risk-Taking | 9 | 2020 | 451 | 1.590 |
Why?
|
Humans | 61 | 2023 | 37093 | 1.430 |
Why?
|
United States | 22 | 2023 | 4223 | 1.420 |
Why?
|
Anti-HIV Agents | 3 | 2022 | 420 | 1.260 |
Why?
|
Patient Selection | 2 | 2020 | 164 | 1.250 |
Why?
|
Substance-Related Disorders | 4 | 2016 | 730 | 1.240 |
Why?
|
Counseling | 4 | 2022 | 116 | 1.220 |
Why?
|
Young Adult | 16 | 2020 | 4268 | 1.030 |
Why?
|
Diagnostic Tests, Routine | 2 | 2015 | 47 | 1.000 |
Why?
|
Middle Aged | 20 | 2020 | 10129 | 0.880 |
Why?
|
Health Status | 3 | 2018 | 380 | 0.860 |
Why?
|
Patient Preference | 1 | 2023 | 44 | 0.860 |
Why?
|
Truth Disclosure | 4 | 2018 | 26 | 0.850 |
Why?
|
Military Personnel | 1 | 2023 | 90 | 0.800 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2020 | 268 | 0.780 |
Why?
|
Adolescent | 12 | 2023 | 5363 | 0.780 |
Why?
|
Safe Sex | 3 | 2016 | 76 | 0.700 |
Why?
|
Disclosure | 1 | 2018 | 34 | 0.640 |
Why?
|
Condoms | 6 | 2023 | 135 | 0.630 |
Why?
|
Patient Participation | 1 | 2018 | 75 | 0.580 |
Why?
|
Anti-Infective Agents | 1 | 2016 | 64 | 0.540 |
Why?
|
Post-Exposure Prophylaxis | 1 | 2015 | 10 | 0.540 |
Why?
|
Health Education | 1 | 2019 | 338 | 0.540 |
Why?
|
Communication | 4 | 2021 | 180 | 0.530 |
Why?
|
Radiography, Interventional | 2 | 2018 | 4 | 0.500 |
Why?
|
Aged | 9 | 2016 | 6741 | 0.490 |
Why?
|
Voluntary Programs | 1 | 2014 | 4 | 0.470 |
Why?
|
AIDS Serodiagnosis | 1 | 2014 | 25 | 0.470 |
Why?
|
Physician-Patient Relations | 1 | 2014 | 128 | 0.450 |
Why?
|
Insurance, Health | 1 | 2014 | 126 | 0.450 |
Why?
|
Urban Population | 1 | 2015 | 333 | 0.430 |
Why?
|
Syphilis | 1 | 2012 | 23 | 0.430 |
Why?
|
Gonorrhea | 1 | 2012 | 24 | 0.420 |
Why?
|
Risk Reduction Behavior | 1 | 2013 | 127 | 0.420 |
Why?
|
Men's Health | 1 | 2012 | 9 | 0.410 |
Why?
|
Bisexuality | 1 | 2014 | 208 | 0.390 |
Why?
|
Attitude to Health | 1 | 2014 | 325 | 0.380 |
Why?
|
Heterosexuality | 4 | 2022 | 88 | 0.370 |
Why?
|
Chlamydia Infections | 1 | 2012 | 196 | 0.370 |
Why?
|
Interviews as Topic | 3 | 2016 | 381 | 0.340 |
Why?
|
Hepatic Artery | 1 | 2008 | 2 | 0.340 |
Why?
|
Embolization, Therapeutic | 1 | 2008 | 19 | 0.330 |
Why?
|
Socioeconomic Factors | 3 | 2020 | 1067 | 0.320 |
Why?
|
Papillomavirus Infections | 1 | 2012 | 336 | 0.310 |
Why?
|
Ambulatory Care | 1 | 2008 | 75 | 0.310 |
Why?
|
Time Factors | 3 | 2018 | 1742 | 0.290 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2008 | 145 | 0.280 |
Why?
|
Liver Neoplasms | 1 | 2008 | 190 | 0.270 |
Why?
|
Female | 11 | 2023 | 20969 | 0.270 |
Why?
|
Logistic Models | 3 | 2013 | 923 | 0.260 |
Why?
|
Physicians | 2 | 2018 | 163 | 0.250 |
Why?
|
Feasibility Studies | 2 | 2020 | 208 | 0.250 |
Why?
|
Qualitative Research | 2 | 2016 | 446 | 0.230 |
Why?
|
Decision Making | 2 | 2018 | 203 | 0.230 |
Why?
|
Minority Groups | 2 | 2020 | 596 | 0.220 |
Why?
|
Multivariate Analysis | 2 | 2015 | 583 | 0.220 |
Why?
|
Choice Behavior | 1 | 2023 | 79 | 0.210 |
Why?
|
Washington | 2 | 2012 | 31 | 0.210 |
Why?
|
Oregon | 2 | 2012 | 43 | 0.210 |
Why?
|
Health Services Research | 1 | 2023 | 148 | 0.210 |
Why?
|
Peru | 1 | 2020 | 30 | 0.190 |
Why?
|
Men | 1 | 2020 | 19 | 0.190 |
Why?
|
Developing Countries | 1 | 2020 | 99 | 0.180 |
Why?
|
Delivery of Health Care | 1 | 2023 | 276 | 0.180 |
Why?
|
Antibiotic Prophylaxis | 1 | 2018 | 7 | 0.160 |
Why?
|
Vascular Surgical Procedures | 1 | 2018 | 14 | 0.160 |
Why?
|
Social Support | 1 | 2021 | 394 | 0.160 |
Why?
|
Surgical Wound Infection | 1 | 2018 | 16 | 0.160 |
Why?
|
Serologic Tests | 1 | 2018 | 43 | 0.150 |
Why?
|
Administration, Rectal | 1 | 2016 | 18 | 0.140 |
Why?
|
Enema | 1 | 2016 | 10 | 0.140 |
Why?
|
Safety | 1 | 2017 | 48 | 0.140 |
Why?
|
Health Policy | 1 | 2018 | 165 | 0.140 |
Why?
|
Risk Factors | 3 | 2018 | 3562 | 0.140 |
Why?
|
Sexuality | 1 | 2016 | 52 | 0.130 |
Why?
|
Anti-Bacterial Agents | 1 | 2018 | 352 | 0.130 |
Why?
|
Depression | 1 | 2022 | 712 | 0.130 |
Why?
|
Prejudice | 1 | 2016 | 110 | 0.130 |
Why?
|
Parents | 1 | 2018 | 329 | 0.130 |
Why?
|
Demography | 1 | 2015 | 175 | 0.120 |
Why?
|
Pentanols | 1 | 2014 | 3 | 0.120 |
Why?
|
Self Disclosure | 1 | 2014 | 42 | 0.120 |
Why?
|
Nitrates | 1 | 2014 | 40 | 0.120 |
Why?
|
Aged, 80 and over | 2 | 2012 | 2379 | 0.120 |
Why?
|
Attitude of Health Personnel | 1 | 2016 | 198 | 0.120 |
Why?
|
Personal Satisfaction | 1 | 2014 | 64 | 0.120 |
Why?
|
Age Factors | 2 | 2018 | 1033 | 0.120 |
Why?
|
Marijuana Smoking | 1 | 2014 | 85 | 0.110 |
Why?
|
Data Collection | 1 | 2013 | 194 | 0.110 |
Why?
|
Multilevel Analysis | 1 | 2012 | 16 | 0.110 |
Why?
|
Marital Status | 1 | 2012 | 40 | 0.100 |
Why?
|
Behavioral Risk Factor Surveillance System | 1 | 2012 | 56 | 0.100 |
Why?
|
Hawaii | 1 | 2018 | 1929 | 0.100 |
Why?
|
Prevalence | 1 | 2015 | 1455 | 0.090 |
Why?
|
Treatment Outcome | 2 | 2018 | 1369 | 0.090 |
Why?
|
Catheterization | 1 | 2008 | 24 | 0.080 |
Why?
|
New York | 1 | 2022 | 71 | 0.050 |
Why?
|
Texas | 1 | 2023 | 324 | 0.050 |
Why?
|
Plant Proteins | 1 | 2022 | 93 | 0.050 |
Why?
|
Contraceptive Agents | 1 | 2020 | 13 | 0.050 |
Why?
|
Pilot Projects | 1 | 2022 | 661 | 0.050 |
Why?
|
Contraception | 1 | 2020 | 57 | 0.040 |
Why?
|
Income | 1 | 2020 | 140 | 0.040 |
Why?
|
Consensus | 1 | 2018 | 45 | 0.040 |
Why?
|
Education, Medical, Continuing | 1 | 2018 | 32 | 0.040 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 143 | 0.040 |
Why?
|
Drug Resistance, Bacterial | 1 | 2018 | 77 | 0.040 |
Why?
|
Curriculum | 1 | 2018 | 265 | 0.030 |
Why?
|
Hospitals, University | 1 | 2016 | 38 | 0.030 |
Why?
|
Tennessee | 1 | 2016 | 70 | 0.030 |
Why?
|
Inservice Training | 1 | 2016 | 33 | 0.030 |
Why?
|
Hospitals | 1 | 2016 | 86 | 0.030 |
Why?
|
Child | 1 | 2022 | 3131 | 0.030 |
Why?
|